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Present-day members of the Chlamydiaceae contain parasitic bacteria that have been co-evolving 
with their eukaryotic hosts over hundreds of millions of years. Likewise, a type III secretion 
system encoded within all genomes has been refined to complement the unique obligate 
intracellular niche colonized so successfully by Chlamydia spp. All this adaptation has occurred 
in the apparent absence of the horizontal gene transfer responsible for creating the wide range 
of diversity in other Gram-negative, type III-expressing bacteria.  The result is a system that is, in 
many ways, uniquely chlamydial. A critical mass of information has been amassed that sheds 
significant light on how the chlamydial secretion system functions and contributes to an obligate 
intracellular lifestyle. Although the overall mechanism is certainly similar to homologous systems, 
an image has emerged where the chlamydial secretion system is essential for both survival 
and virulence. Numerous apparent differences, some subtle and some profound, differentiate 
chlamydial type III secretion from others. Herein, we provide a comprehensive review of the 
current state of knowledge regarding the Chlamydia type III secretion mechanism. We focus on 
the aspects that are distinctly chlamydial and comment on how this important system influences 
chlamydial pathogenesis. Gaining a grasp on this fascinating system has been challenging in 
the absence of a tractable genetic system. However, the surface of this tough nut has been 
scored and the future promises to be fruitful and revealing.
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Gram-negative pathogens where they are essential for virulence (He 
et al., 2004). Intriguingly, the T3SS has also been shown to mediate 
symbiotic relationships and more recently, several non-pathogenic 
organisms have been found to contain T3SS genes (Krishnan et al., 
2003; Tampakaki, 2004; Pallen et al., 2005). We will employ the term 
“non-flagellar T3SS (NF-T3SS)” throughout this review to differen-
tiate from the process of flagellar biogenesis and in reference to the 
broader capacity of T3S to mediate interactions between bacteria and 
a respective eukaryotic host cell (Pallen et al., 2005).
The NF-T3SS is often referred to as acting like a “molecular 
syringe” to deliver anti-host bacterial “effector” proteins directly 
into a host cell in a contiguous process (Hueck, 1998). Essential 
components of the NF-T3SS (Figure 1) include (i) ancillary com-
ponents  (AC)  functioning  within  the  bacterial  cytoplasm  and 
represented by a set of chaperones and regulatory factors, (ii) 
membrane-associated gene products that form a multipartite core 
secretory apparatus that is highly conserved among systems, (iii) 
proteins comprising an extended needle and tip complex (NC and 
TC, respectively) which bridges the space between bacterium and 
host membranes, and (iv) secreted translocon (Tr) proteins required 
to form pores in eukaryotic membranes through which secretion 
substrates gain access to the host cytosol (Ghosh, 2004; Tampakaki, 
2004). Collectively referred to as the “injectisome”, secretion activity 
of these machines is tightly regulated and stimulated only upon 
contact with target host molecules. The reader is referred to several 
recent reviews for a detailed overview of the T3S mechanism in 
other bacteria (Moraes et al., 2008; Mueller et al., 2008; Marlovits 
and Stebbins, 2009; Beeckman and Vanrompay, 2010).
IntroductIon
The Family Chlamydiaceae contains obligate intracellular, Gram-
negative bacteria capable of infecting an impressive array of hosts 
including reptiles, amphibians, and animals. Three species, C. tracho-
matis, C. pneumoniae, and the zoonotically acquired C. psittaci, are 
significantly associated with human disease. Ocular (serovars A–C) 
or genital (serovars D–K, L1–L3) infections with C. trachomatis 
represent leading causes of infectious blindness and sexually trans-
mitted disease, respectively. C. pneumoniae is a common respira-
tory pathogen associated with relatively mild, community- acquired 
pneumonias (Kuo et al., 1995), whereas C. psittaci respiratory infec-
tions, acquired rarely from an avian reservoir, cause an atypical 
pneumonia which can be fatal (Sessa et al., 2009). The prevalence of 
Chlamydia-mediated human disease, the overall broad host range, 
and the identification of environmental Chlamydia-like organisms 
has led to the assertion that the Chlamydiales represent a group of 
successful parasites that are virtually ubiquitous in nature.
Indeed, considerable effort has been invested to elucidate molecular 
mechanisms that contribute to this overall success. As obligate intrac-
ellular pathogens expressing a minimal genome, many distinct factors 
likely orchestrate an intricate and highly interdependent manipulation 
of host cell biology to culminate in successful pathogenesis. The type 
III secretion system (T3SS) has emerged as one mechanism capable 
of promoting chlamydial virulence. Genes encoding the virulence-
associated T3SS were first identified in Yersinia spp. (Hueck, 1998) and 
subsequent characterization of the archetype Ysc-Yop system revealed 
an intricate bacterial mechanism to subvert eukaryotic hosts. T3SSs 
have since been identified in a wide variety of medically significant Frontiers in Microbiology  |  Cellular and Infection Microbiology    October 2010  | Volume 1  | Article 114  |  2
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et al., 2009; Cocchiaro and Valdivia, 2009). In this review, we will 
focus on the chlamydial T3S apparatus and comprehensively exam-
ine current knowledge regarding the mechanics of this remarkable 
nanomachine in Chlamydia spp. Rather than focus solely on how 
the chlamydial T3SS is the same as prototypical systems, we will 
emphasize variations found in Chlamydia (summarized in Table 1). 
We  endeavor  herein  to  consider  how  these  variable  attributes 
respond to, govern, or otherwise contribute to the successful obli-
gate intracellular lifestyle exemplified by Chlamydia spp.
A thorough consideration of the chlamydial T3SS cannot pro-
ceed without comment on key aspects of chlamydial physiology 
and development. For example, Chlamydia spp. possess an atypical 
peptidoglycan layer (McCoy et al., 2006). Osmotic stability of infec-
tious particles is instead likely conferred predominantly by disulfide 
bonding of cysteine-rich outer membrane (OM) and periplasmic 
proteins (Hatch, 1996). Therefore, the chlamydial T3SS need not 
contend with remodeling a dense peptidoglycan layer but must 
accommodate a disulfide linked envelope that is reduced during 
vegetative growth and oxidized in infectious particles. All Chlamydia 
spp. exhibit a unique bi-phasic developmental cycle which occurs 
within parasitophorous membrane bound vesicles, termed inclu-
sions. Development is manifested when infectious, metabolically 
inert elementary bodies (EBs) invade epithelial cells and begin to 
differentiate into vegetative, non-infectious, metabolically active 
reticulate bodies (RBs). RBs replicate within the expanding inclu-
sion before they differentiate back into EBs that are subsequently 
released, completing the developmental cycle (Abdelrahman and 
Belland, 2005). As emphasized below, the chlamydial T3SS is present 
and functional at each stage of this complex cycle.
The unique physiology noted above results in salient and subtle 
differences between the chlamydial T3S machinery and other systems. 
In the following section we will discuss characterized components 
of the chlamydial T3SS and, where appropriate, speculate on latent 
  candidates. A T3SS-specific nomenclature based on the character-
ized Yersinia system was suggested by Hsia et al. (1997) where com-
ponents of the basal apparatus are denoted with contact-dependent 
secretion (Cds), secreted or mobile components as Chlamydia outer 
protein (Cop), and cytoplasmic chaperones as specific Chlamydia 
chaperone (Scc). We will continue to use this nomenclature herein. 
To maintain conciseness, only designations found in the C. tracho-
matis serovar D genome database
1 will be employed when function 
is ambiguous or names have not been formally assigned.
orIgIn and functIon of the chlamydIal t3SS
Generally, genes encoding components of the T3SS apparatus are 
clustered together in pathogenicity islands (PAIs) on a plasmid or the 
bacterial chromosome. Nucleotide content of T3SS coding sequences 
typically differ from that of the overall genome and are often denoted 
by a low G + C ratio (Tampakaki, 2004). In contrast, chlamydial genome 
analyses indicate a homogenous G+C content for T3SS-encoding 
genes that is similar to the roughly 40% level found in the remainder 
of respective genomes (Stephens et al., 1998). Moreover, T3SS genes 
are disseminated similarly throughout chlamydial genomes in four 
main clusters (Fields and Hackstadt, 2006) arranged into multiple 
operons (Hefty and Stephens, 2007). Although some of the clusters 
In 1997, Hsia et al. identified a locus of four open reading frames 
(ORFs) in C. psittaci with homology to Yersinia T3S proteins YscU, 
LcrD/YscV, YopN, and SycE respectively (Hsia et al., 1997). Initial 
genome sequencing projects then confirmed an entire comple-
ment of conserved, putative T3SS genes in C. trachomatis serovar 
D and C. pneumoniae (Stephens et al., 1998; Kalman et al., 1999). 
Genome sequencing projects have subsequently identified ORFs 
capable of encoding a complete T3SS in all sequenced members 
of the Chlamydiaceae family (Read et al., 2000, 2003; Thomson 
et al., 2005; Azuma et al., 2006) and more recently Chlamydia-
related bacteria infecting amoebae (Bertelli et al., 2010). The T3S 
mechanism is therefore clearly entrenched deeply in the biology 
of these fascinating bacteria. As expected, questions regarding how 
the T3SS functions and contributes to chlamydial survival have 
been slow to find answers. This is largely due to the genetic intrac-
tability of Chlamydia spp. and a complex parasitic developmental 
cycle. In recent years, however, there has been a significant increase 
in our understanding of the role of the NF-T3SS in chlamydial 
pathogenesis and development. Like other NF-T3SSs, the basic 
secretion mechanism is likely conserved. Yet variations, consistent 
with Chlamydia’s unique biology, have been noted. Certainly, the 
emerging complement of niche-specific, secreted effector proteins 
provides a significant basis for distinctive biology. In fact, several 
recent reviews provide excellent overviews of chlamydial effector 
proteins deployed by the T3S mechanism (Valdivia, 2008; Betts 
Figure 1 | Schematic representation of a prototypical T3S injectisome. 
Components including the translocator (Tr), tip (TC), and needle (NC) 
complexes, basal apparatus, and cytoplasmic ancillary proteins (AC) are 
shown. The basal apparatus spans the bacterial inner membrane (IM), 
periplasm (PP), and outer membrane (OM). Secreted translocon components 
are shown localized to a host membrane (HM). Correct stoichiometry of 
multimeric proteins is not indicated.
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Table 1 | Distinguishing features of Chlamydia T3SS componentsa.
Chlamydial T3SS 
componentb
Yersinia 
counterpart
Putative function Chlamydia-specific properties
CHApERonEs And REgulAtoRY
Scc2 (CT576) SycD Class II chaperone for CopB Basic PI, unique N-terminal consisting of 60 residues which 
do not share homology with other proteins in the data base 
or Scc3
Scc3 (CT862) SycD Class II chaperone CopB2 Neutral PI, unique 60 residue N-terminal region containing a 
canonical amphipathic helix absent in Scc2. Interacts with 
C-terminal domain of CopN in addition to CopB2
CT274 SycD? Putative Class II chaperone by secondary 
structure analysis, interacts with CT161 and 
CT668
“Stand alone” ORFc. Putative Class II TPR containing 
chaperone interacts with putative T3S effectors.
CdsO (CT670) YscO Chaperone for putative molecular ruler, CdsP May interact with CdsN in C. pneumoniae.
Mscs (CT260) Multi-cargo effector chaperone, docks with inner 
membrane component CdsQ to presumably 
facilitate delivery of effectors to CdsN for 
secretion.
“Stand alone” ORF . Able to bind CdsQ directly leading to 
speculation that Mscs dimers may be pre-docked at the 
cytoplasmic portion of the inner membrane C-ring.
CT663 SycH? Putative Class I chaperone, may be involved in 
negative regulation
Class I chaperone able to exert negative regulatory effect on 
σ66-dependent transcription.
CT043 Putative Class I chaperone “Stand alone” ORF
CopN (CT089) YopN T3SS “Plug” . Involved in regulation of secretion 
by maintaining the secretion system in an 
inactive state prior to the presence of an 
inductive signal.
Required to support intracellular growth of C. pneumoniae 
in vitro. Interacts CdsN.
sECREtion AppARAtus
CdsL (CT561) YscL Basal apparatus component interacts with 
CdsQ. Based on homology likely to be involved 
in regulation of CdsN by inhibiting ATPase 
activity. May also be involved in assembly of the 
apparatus
Capable of interacting with the C-terminus of CdsD. Also 
interacts with FliI and FlhA homologues in the Bacterial 
2-hybrid system and pull-down assays
CdsN (CT669) YscN ATPase involved in release of effectors from 
cognate chaperones and unfolding effectors to 
render them secretion competent
Capable of binding with CdsD
CdsQ (CT672) YscQ Cytoplasmic C-ring component of apparatus, 
docks chaperone-effector complexes and 
presumably facilitates effector delivery to CdsN.
Interacts with multiple apparatus components including 
“flagellar homologs”
CdsD (CT664) YscD Likely forms the inner membrane ring with CdsJ Has a unique N-terminus containing an additional FHA 
domain which along with its FHA-2 domain undergoes 
phosphorylation by cytosolic PknD in vitro. Capable of 
interacting with a novel subset of inner membrane proteins.
CdsC (CT674) YscC Outer membrane secretin Large unique N-terminal region comprising a distinctive 
hydrophilic domain that is variable between Chlamydia spp. 
Lacks an obvious lipoprotein pilot required in other 
NF-T3SSs for secretin oligomerization and membrane 
association.
TranSloCaTion MaChinery
CdsF (CT666) YscF Needle subunit protein Contains two cysteine residues at the N-terminus
CT584 LcrV Putative needle tip protein, may be involved in 
host-cell sensing and contact dependent 
activation of the secretion system
“Stand alone” ORF . Not recognized by human serum from 
Chlamydia infected patients
CopB2 (CT861) YopB Possible additional translocator Present in the host-cell cytosol
aOnly components that have features that clearly distinguish them from homologs in other T3SSs are listed.
bComponent genomic designations are indicated based on the annotated genome of C. trachomatis serovar D (Stephens, 1998).
c“Stand alone” ORF designation indicates the respective gene is encoded outside of T3SS-associated loci.Frontiers in Microbiology  |  Cellular and Infection Microbiology    October 2010  | Volume 1  | Article 114  |  4
Betts-Hampikian and Fields  The chlamydial T3S mechanism
Hackstadt, 2000). It is now doubtless that the primary function of 
the chlamydial T3SS is to translocate effector proteins into host cells 
for manipulation of eukaryotic cellular processes. Subsequent stud-
ies have further exploited the use of heterologous secretion systems 
to demonstrate an ability to secrete effector proteins (Subtil et al., 
2001; Fields et al., 2003; Lugert et al., 2004; Ho and Starnbach, 2005). 
Furthermore, the development of small molecule inhibitors of T3S 
has  now  enabled  more  direct  demonstration  of  T3SS-mediated 
secretion of endogenous chlamydial proteins (Nordfelth et al., 2005; 
Muschiol et al., 2006; Wolf et al., 2006; Bailey et al., 2007). We have 
speculated that C. trachomatis may secrete as many as 80 anti-host 
proteins (Betts et al., 2009). This number would be in line with an 
absolute dependence on host cell biology and underscores the impor-
tance of T3S in chlamydial survival. Combined with 20–30 appar-
ent and predicted apparatus components, this T3SS gene content 
would represent roughly 10% of the 894 ORFs predicted within the 
C.   trachomatis serovar D genome. This level of genomic commitment 
raises the possibility that functions beyond secretion of anti-host 
effector proteins likely exist for the chlamydial T3S apparatus. Several 
possibilities where the apparatus itself could contribute directly to 
chlamydial pathogenesis will be elaborated on below.
aSSemblIng the t3SS
the apparatuS Scaffold
Current evidence from genetically tractable systems indicate that 
apparatus assembly is initiated by three proteins: an OM ring pro-
tein, a lipoprotein forming the inner membrane (IM) ring, and an 
IM-associated protein connecting the two rings (Yip et al., 2005; 
Spreter et al., 2009; Diepold et al., 2010). Based on sequence similar-
ity, these proteins would correspond to chlamydial CdsC, CdsJ, and 
CdsD, respectively (Figure 2). It is likely that a similar outside–in 
are flanked by tRNAs, insertion   elements, and gene arrangements 
consistent with horizontal gene transfers or PAIs are lacking. These 
observations have provided the basis for hypotheses proposing that 
the NF-T3SS found in Chlamydia spp. represents an ancestral or 
primordial system (Stephens et al., 1998; Kim, 2001). This notion is 
supported by the identification of T3S genes in the amoeba symbiont 
Parachlamydia sp. UWE25, indicating that T3SS genes were present 
when symbiotic and pathogenic Chlamydia diverged some 700 mil-
lion years ago (Horn et al., 2004; Pallen et al., 2005). Chlamydial 
genomes also contain several T3S components having more robust 
similarity to the flagellar T3SS, raising the possibility that chlamydiae 
represent a missing link in the transformation of flagellar to non-
flagellar T3SSs (Kim, 2001). However, multiple groups have since 
made compelling arguments that flagellar and non-flagellar systems 
evolved divergently from a common ancestor (Gophna et al., 2003; 
Pallen et al., 2005). In addition, it was noted that similar to Chlamydia 
spp., genes encoding one of the NF-T3SSs found in the proteobacte-
rium Chromobacterium violaceum also have G + C content similar to 
the remaining genome and some apparatus components are encoded 
in a separated loci (Betts et al., 2004). Therefore, the evolutionary his-
tory of T3SSs remains clouded. Regardless of precise lineage, it is clear 
that the chlamydial T3SS has evolved in isolation for an evolutionar-
ily significant span of time. This is in agreement with phylogenetic 
analyses that typically sort the chlamydial T3SS to a distinct family 
(Troisfontaines and Cornelis, 2005). One can therefore anticipate a 
great deal of T3S biology that is distinctly chlamydial.
Functionality of the chlamydial T3SS was first demonstrated 
indirectly. The chlamydial homolog of Yersinia YopN termed CopN 
was secreted by a heterologous T3SS when ectopically expressed 
in Yersinia, and immunolocalization data indicated secretion of 
the endogenous protein during chlamydial infection (Fields and 
Figure 2 | a working model for the temporal assembly and composition of the chlamydial T3S apparatus. Stepwise addition of proteins is indicated with 
newly added components shown in blue and previously assembled components in gray (shown with Cds letter designation only). The basal apparatus spans the 
chlamydial inner membrane (IM), OmcB-containing P-layer (P), and outer membrane (OM). Flagellar homologs are omitted for clarity.www.frontiersin.org  October 2010  | Volume 1  | Article 114  |  5
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would be consistent with at least some portion of CdsD being 
exposed to the chlamydial cytoplasm. More direct evidence for this 
exposure is apparent since both FHA domains have recently been 
shown (Johnson and Mahony, 2007) in vitro to be substrates for 
protein kinasae D (PknD). PknD is one of two currently identi-
fied chlamydial eukaryotic-like, IM-associated serine/threonine 
protein kinases (STPK) having confirmed activity (Verma and 
Maurelli, 2003). Moreover, PknD may play a role in chlamydial 
replication (Johnson et al., 2009). Unfortunately technical obsta-
cles have so far precluded corroboration of CdsD phosphorylation 
in vivo so it is unclear how this may correspond to T3SS activity. 
Regardless, CdsD represents the first example of a T3SS apparatus 
protein that has been shown to undergo phosphorylation (Virok 
et al., 2005; Johnson and Mahony, 2007; Johnson et al., 2009). 
Considerable questions remain regarding CdsD contribution to 
chlamydial T3S. Although a single transmembrane domain is pre-
dicted, Triton X-114 solubility is inconsistent with CdsD being an 
integral membrane protein (Johnson et al., 2008). The interaction 
with cytoplasmic proteins renders it difficult to then understand 
assembly is conserved in Chlamydia spp. Similar to their homologs, 
CdsC and CdsJ possess predicted Sec-dependent secretion signals 
that would be necessary for membrane access prior to injectisome 
assembly. Moreover, both CdsC and CdsJ partition as integral mem-
brane proteins after Triton X-114 extraction of EBs (Fields et al., 
2003). As predicted, CdsC is detectible in chlamydial OM complexes 
(Betts et al., 2008; Birkelund et al., 2009; Liu et al., 2010), whereas 
most of CdsJ is absent from this fraction (Betts et al., 2008). Aside 
from modeling predictions that indicate CdsJ is a lipoprotein, direct 
characterization of this protein is yet forthcoming. Consideration 
of CdsC and CdsD, however, reveals potentially interesting insights 
into the chlamydial system.
Based on sequence similarity, CdsC is a member of the PulD fam-
ily of OM secretins (Hueck, 1998). Interestingly, primary sequence 
analysis reveals that the N-terminal 250 residues of CdsC comprise 
a distinctive hydrophilic domain that is unique to chlamydial CdsC 
yet divergent in primary sequence among chlamydial species. What 
additional function could be conveyed by this domain remains 
unclear as no significant homologies are detected via PSI-BLAST. 
Direct evidence for the predicted multimerization is lacking, and 
a lipoprotein pilot commonly required for other secretins to oli-
gomerize and become membrane associated (Hueck, 1998) has not 
been identified for Chlamydia spp. This is perhaps not surprising 
given that pilot proteins typically display <15% sequence simi-
larity among NF-T3SSs (Okon et al., 2008). However, structures 
formed by homologs of CdsC are similar in morphology to the 
multimeric, “rosette-like” structures first observed on C. psittaci 
EBs (Matsumoto, 1982b). Other candidates such as C. trachomatis 
PmpD have been proposed for these structures (Crane et al., 2006), 
yet it seems equally reasonable that they will correspond to the T3SS 
apparatus. Biochemical extraction data indicate that portions of 
CdsC are almost certainly surface-exposed (Betts et al., 2008) and 
Peters et al., (2007) pointed out that, in addition to looking very 
much like other T3SS rings in electron micrographs, the apparent 
inner diameter of the rosettes is similar to those of OM rings in 
Yersinia and Salmonella.
Chlamydial CdsD represents a novel member of the YscD fam-
ily of proteins, which in Yersinia forms the IM ring in conjunc-
tion with YscJ (Silvia-Herzog et al., 2008; Diepold et al., 2010). 
Interestingly, only the ca. 400 C-terminal residues of CdsD con-
tain regions of similarity to members of the YscD family includ-
ing putative transmembrane and phospholipid binding (BON) 
domains (Johnson et al., 2008). YscD family proteins also con-
tain an forkhead associated (FHA)-like domain at the N-terminus 
(Pallen et al., 2005). FHA domains are often involved in medi-
ating  phosphorylation  dependent  protein-protein  interactions 
via phospho-serine or phospho-threonine peptides (Durocher 
et al., 2000). CdsD contains two predicted FHA domains, FHA-1 
within the first 100 residues and FHA-2 within the C-terminal 
region that contains YscD similarity. It should be pointed out 
that early studies suggested that CdsD may be surface exposed 
on EBs or even secreted during infection (Tanzer and Hatch, 2001; 
Herrmann et al., 2006). However, the weight of evidence now casts 
doubt on those interpretations. For example, protein interaction 
studies (Figure 3) have provided evidence for the C-terminus of 
CdsD interacting with IM-associated T3S proteins CdsL, CdsQ 
(Johnson et al., 2008), and CdsN (Stone et al., 2008). These data 
Figure 3 | Summary model of protein–protein interactions among 
chlamydial T3SS components. Respective proteins are placed based on 
homology to components in other T3SSs (gray) or based on published in vitro 
or in vivo data in Chlamydia (blue). Interactions are depicted as dashed lines 
for predicted interactions or solid lines for those that have been established 
experimentally. Flagellar homologs are omitted for clarity.Frontiers in Microbiology  |  Cellular and Infection Microbiology    October 2010  | Volume 1  | Article 114  |  6
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putative flagella homologs and several of the IM components of the 
C.   pneumoniae T3SS (Stone et al., 2010). The presence of a handful 
of flagella genes in chlamydial genomes represents an enigma (Fields 
and Hackstadt, 2006; Peters et al., 2007). In C. trachomatis, CT060 
(CdsV paralog) encodes an ortholog of FlhA, an essential integral 
membrane component of the flagella basal body ring. CT061 is 
orthologous to FliA, the flagella sigma factor (Macnab, 2004). A 
second small cluster comprises CT717–CT719 encoding orthologs 
of FliI (CdsN paralog), the flagella ATPase, a homolog of FliH (CdsL 
paralog) which is a negative regulator of FliI, and FliF (CdsJ paralog) 
the MS ring protein, respectively (Macnab, 2004; Peters et al., 2007; 
Stone et al., 2010). In C. pneumoniae several interactions between 
putative flagella components were observed (Stone et al., 2010). FliI 
was found to have ATPase activity similar to CdsN, and interacted 
with the cytoplasmic domain of FlhA. FlhA in turn interacted with 
the C-terminal region of FliF. Cpn0859 (a FliH homolog by PSI-
BLAST analysis) was found to homodimerize and interact with 
FliI and FlhA in pull-down assays. These findings are all consistent 
with counterparts from other flagella systems. Although an interac-
tion between the putative FliH homolog Cpn0859 and the ATPase 
FliI was established, the authors concluded that Cpn0859 is not a 
FliH ortholog since it was not found to have regulatory function. 
However, rigorous PSI-BLAST scores argue for the FliH designa-
tion and lack of activity could simply be due to technical failure 
of an in vitro system. Certainly the most interesting aspect of this 
study is derived from interactions identified between the flagella 
orthologs and IM components of the NF-T3SS. Using the Bacterial-
2-hybrid system and co-purification assays, identified interaction 
partners included FliI-CdsL, FlhA-CdsL, FliI-CopN, FlhA-CdsU 
(Stone et al., 2010), and FlhA-CdsQ (Spaeth et al., 2009). The fact 
that Chlamydia are non-motile and do not possess a full reper-
toire of flagella genes is an exciting conundrum (Abdelrahman 
and Belland, 2005; Peters et al., 2007; Stone et al., 2010), and a 
minimalist genome demands function for retained genes. We favor 
a model where a hybrid apparatus is formed incorporating these 
flagella components into the basal apparatus. Thus, interchanging 
key apparatus components could result in functionally distinct 
machinery that correlates with or is dependent on the chlamydial 
developmental cycle (Stone et al., 2010). This hypothesis is con-
sistent with the observations that “flagellar” genes are consistently 
transcribed earlier in C. trachomatis (Belland et al., 2003) and C. 
pneumoniae (Maurer et al., 2007) development than corresponding 
paralogs. Clearly, this area represents another exciting facet of the 
chlamydial T3SS that requires and warrants further study.
the extra-cellular InjectISome
Once a secretion-competent basal apparatus is completed, com-
ponents can be exported that form exterior structures. Extra-
cellular components of a prototypical T3SS contain a needle, tip, 
and a pair of translocator proteins (Mueller et al., 2008). Under 
non-secreting conditions the needle is “capped” by a tip protein 
that is likely involved in sensing contact with the host cell and 
subsequently  triggers  active  secretion.  Upon  activation,  trans-
locator proteins are the first to be exported and are required to 
form a pore in the cytoplasmic membrane consequently allowing 
direct translocation of the effector substrates (Mota, 2006; Broz 
et al., 2007). Bioinformatic and biochemical analyses were used to 
how CdsD could interact with CdsC to serve its presumed scaf-
folding function in the IM ring. Clearly, much more information 
is required.
Inner membrane componentS
Presently, there are only a handful of studies regarding additional 
components that form the multipartite IM core of the chlamydial 
NF-T3SS. Homology searches indicate that the composition is simi-
lar to the Yersinia apparatus with integral IM components consist-
ing of Cds R/S/T/U/V and peripherally IM-associated components 
Cds L/N/Q (Fields and Hackstadt, 2006). Recent studies relating 
directly to protein–protein interactions of the chlamydial appara-
tus components have been particularly illuminating (Figure 3). 
Consistent with other NF-T3SSs, these studies indicated that CdsQ 
likely forms an important platform for structural integrity and 
secretion activity of the chlamydial T3SS. CdsQ homologs interact 
with other IM components of the apparatus to form the inner 
C-ring complex (Jackson and Plano, 2000; Fadouloglou et al., 2004; 
Gonzalez-Pedrajo et al., 2006; Morita-Ishihara et al., 2006; Riordan 
and Schneewind, 2008; Diepold et al., 2010). In Chlamydia, asso-
ciation with the IM is apparently mediated by multiple proteins. 
A combination of GST-fusion co-precipitations and two-hybrid 
studies using C. trachomatis and C. pneumoniae proteins were used 
to identify direct CdsQ interactions with IM components CdsD 
(Johnson et al., 2008), CdsS, and CdsT (Spaeth et al., 2009). An 
interaction between CdsQ and CdsV was not detected but instead 
CdsQ interacted with CT060, the flagella homolog of CdsV (Spaeth 
et al., 2009). In accordance with its counterparts in Yersinia and 
Shigella, Chlamyida CdsQ was found to interact with itself (Johnson 
et al., 2008) and the peripheral IM component CdsL (Johnson et al., 
2008; Spaeth et al., 2009). Interestingly, a direct interaction of CdsQ 
was also detected with CdsN (Stone et al., 2008), a secretion chap-
erone (discussed below), and currently undefined proteins (Spaeth 
et al., 2009), further supporting the importance of this protein as 
an integral linchpin in the chlamydial NF-T3S process.
The  close  association  of  CdsL  and  CdsN  warrants  further 
exploration. Chlamydia CdsN is homologous to the T3S family 
of ATPases having similarity to the β subunit of the F0F1 ATPases 
(Hueck, 1998). This class of ATPases plays an important role in 
release of effectors from their chaperones and unfolding effectors 
at the IM to render them secretion competent (Akeda and Galan, 
2004). C. pneumoniae CdsN oligomerizes in solution and hydro-
lyzes ATP in a time- and dose-dependent manner (Stone et al., 
2008). CdsN interaction with CdsL likely facilitates CdsL-mediated 
regulation of CdsN by inhibiting its ATPase activity (Blaylock et al., 
2006; Stone et al., 2008). In addition to interactions with CdsL and 
CdsQ, potentially novel interactions (Stone et al., 2008) have been 
detected with apparatus components CdsD, CdsO, and CopN (dis-
cussed below). In accordance with putative function in modulating 
effector folding, a weak interaction between C. trachomatis CdsN 
and the apparent effector protein CT621 (Hobolt-Pederson et al., 
2009) was detected in yeast two-hybrid studies (Spaeth et al., 2009). 
These interactions are likely dynamic in vivo and would orchestrate 
regulated donation of secretion substrates to the T3S apparatus.
Many of the IM components of the virulence-associated T3SS 
are  homologous  with  IM  components  of  the  flagellar  T3SS. 
Intriguingly a recent study has demonstrated interactions between www.frontiersin.org  October 2010  | Volume 1  | Article 114  |  7
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2003). In addition it has been postulated that they are required to 
maintain substrates in a secretion competent state and may also be 
involved in coordinating secretion to ensure secreted components 
are released in the correct order (Akeda and Galan, 2005). T3SS 
chaperones can be separated into several general classes based on 
the nature of their cognate substrates and structural conservation. 
For example Class IA chaperone one effector, Class IB chaperone 
multiple effectors and both adopt similar homo-dimeric structural 
folds (Parsot et al., 2003). Class II chaperone translocator proteins 
are structurally distinct, typically containing three tetratricopep-
tide repeat (TPR) motifs (Pallen et al., 2003). Recently, a third 
class (Class III) has been recognized that chaperone extra-cellular 
filament proteins and assume an extended alpha helical structure 
(Quinaud et al., 2005; Yip et al., 2005; Quinaud et al., 2007; Betts 
et al., 2008). Studies identifying a number of T3S chaperones have 
begun to reveal a uniquely complex picture regarding chlamydial 
T3SS chaperones. Demonstrated or potential C. trachomatis T3SS 
chaperones include: Scc1, Scc2, Scc3, CdsE, CdsG, CT043, CT260, 
CT274, and CT663 (Fields and Hackstadt, 2006; Spaeth et al., 2009). 
This is a suspiciously small number of potential chaperones given 
the number of predicted secretion substrates. However, it is clear 
from other systems that not all effectors require chaperones (Page 
and Parsot, 2002; Feldman and Cornelis, 2003) and a picture is 
emerging in Chlamydia that a single chaperone can indeed associate 
with multiple T3S substrates.
According to similarities in primary sequence, predicted sec-
ondary structure, and deduced biochemical parameters with pro-
totypical chaperones, CT043, Scc1, and CT663 would represent 
chlamydial  Class  IA  chaperones  (Fields  and  Hackstadt,  2006). 
Currently, no interaction partners for CT043 have been identi-
fied. Generally effectors are encoded close to their chaperones, yet 
CT043 is flanked by genes involved in glycogen metabolism and 
DNA replication. However, since several of the chlamydial effectors 
as well as other chaperones (CT274 and CT260) apparently “stand 
alone” in the genome, this cannot be considered anomalous. On 
the contrary, the scattering of type-III related ORFs is certainly 
one of the distinguishing features of the chlamydial T3SS. It is 
possible that CT043 represents a multi-cargo effector chaperone, 
and like CesT’s involvement with at least seven E. coli effectors, 
may be capable of interacting with a significant number of T3S 
substrates (Thomas et al., 2005). Analyses of Scc1 and CT663 con-
found typical classification. Instead of interacting with secretion 
substrates, yeast two-hybrid data indicate they interact with each 
other (Spaeth et al., 2009). Hence Scc1 and CT663 likely constitute 
a heterodimeric chaperone. Although a corresponding secretion 
substrate awaits identification, CT663 may play an additional role 
in regulation (discussed below) through an interaction with RNA 
polymerase (Rao et al., 2009).
An  extensive  yeast  two-hybrid  screen  identified  a  unique 
chlamydial protein that represents a new Class IB T3S chaperone 
capable of binding several effectors (Spaeth et al., 2009). CT260/
multiple cargo secretion chaperone (Mcsc) is at the center of a 
protein–  protein interaction hub involving three inclusion mem-
brane proteins, Cap1, CT618, and CT225, respectively and the cyto-
plasmic C-ring of the apparatus, CdsQ. The data suggest that Mcsc 
is required to stabilize Cap1 and CT618 in the bacterial cytosol and 
may facilitate their delivery to the ATPase of the secretion appara-
demonstrate that   surface-localized CdsF polymerizes to form the 
Chlamydia   needle (Betts et al., 2008). CdsF is highly conserved 
among chlamydial species and, similar to other NF-T3S needle 
proteins, is comprised of two predicted helices connected by a loop 
region. In addition, CdsF interacts with a heterodimeric chaper-
one (described below) and C. trachomatis CT584 (Spaeth et al., 
2009). Although the primary sequence of CT584 lacks similarity 
to other tip proteins, biophysical characterization and structural 
modeling indicate that CT584 likely encodes the chlamydial tip 
protein (Markham et al., 2009). This would be consistent with the 
interaction with CdsF. Importantly, needle and tip proteins from 
other systems are antigenic and specific antibodies often confer pro-
tection from lethal challenge in animal models (Leary et al., 1995; 
Matson et al., 2005). However, current studies indicate that neither 
CdsF nor CT584 induce significant antibody responses in C. tracho-
matis infected humans (Wang et al., 2010). While it remains to be 
tested whether antibodies that do arise have neutralizing potential, 
it is entirely possible that, given an absolute dependence on T3SS for 
growth, chlamydial components have evolved to be less antigenic 
than counterparts in facultative and extra-cellular organisms.
The  T3SS  apparatus  is  completed  by  translocator  proteins 
which presumably oligomerize to form a hetero-oligomeric pore 
in the host cell cytoplasmic membrane. In the case of Chlamydia 
this would also include the inclusion membrane. Chlamydia spp. 
potentially encode two sets of translocators and this may make 
sense if functionally distinct T3SSs occur in chlamydiae as discussed 
above. Gene products CopB and CopB2 are both secreted via a T3S 
mechanism (Fields et al., 2005; Subtil et al., 2005). In addition, 
they resemble translocator proteins in predicted structure, and are 
encoded downstream of genes encoding homologous chaperones 
(Scc2 and Scc3) and proteins (CopD and CopD2) having charac-
teristics common to additional translocator proteins (Pallen et al., 
1997, 2005). CopB would be predicted to act as a translocator with 
secreted CopD (Ho and Starnbach, 2005) whereas CopB2 would 
presumably pair with CopD2. Intuitively a second translocator set 
would be required since CopB is not transcribed until late-cycle 
(discussed below). Although CopB could likely enable transloca-
tion during invasion, it is unclear how it could function as RBs 
begin to divide. Unfortunately, endogenous CopB2 (unlike CopB) 
is not detectable in either C. trachomatis (Fields et al., 2005) or C. 
pneumoniae (Lugert et al., 2004) inclusion membranes and does not 
fractionate as an integral membrane protein (Fields, unpublished). 
If CopB2 has translocator activity, it is certainly atypical. Some 
translocators in other systems have been shown to have additional 
effector functions (Hamaguchi et al., 2008; Hamada et al., 2010) and 
it is also possible that CopB2 has diverged to accomplish this role. 
This hypothesis would be supported by apparent co-localization of 
ectopically expressed C. pneumoniae CopB2 with host endoplasmic 
reticulum (Muller et al., 2008).
chaperoneS
Molecular chaperones play a pivotal role in T3S via their inter-
action with translocator and effector molecules in the bacterial 
cytosol. They are involved in prevention of substrate degradation 
prior to secretion, delivery of the substrate to the apparatus, pre-
vention of substrate aggregation and premature interaction, and 
transcriptional regulation of T3S genes (Feldman and Cornelis, Frontiers in Microbiology  |  Cellular and Infection Microbiology    October 2010  | Volume 1  | Article 114  |  8
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(Gupta and Griffiths, 2006; Lorenzini et al., 2010). Located in the 
same T3SS gene cluster as CdsD/E/F/G, gene order conservation 
suggests CT670 may be analogous to YscO, an essential multi-
functional component of the Yersinia T3SS that is required for 
effector export and secretion of the “molecular ruler” protein YscP 
(Journet et al., 2003; Riordan et al., 2008). Lorenzini et al. provided 
compelling in silico and in vitro evidence, including protein crystal-
lization, that CT670 is indeed a YscO homolog and should now 
be considered CdsO. In addition, a chaperone function for CdsO 
is supported by the demonstration of CdsO interaction with the 
secreted protein CT671 (Subtil et al., 2005) which likely represents 
the homolog of Yersinia YscP. CdsO was also found to interact with 
itself in C. pneumoniae (Stone et al., 2008); thus being consistent 
with other T3S chaperones which typically dimerize (Page and 
Parsot, 2002). Interestingly, an interaction between CdsO and the 
ATPase CdsN was demonstrated in C. pneumoniae. This lead to 
speculation that C. pneumoniae CdsO may also act as a chaperone 
for CdsN (Stone et al., 2008). However, since there is considerable 
evidence that Yersinia YscO is also capable of interactions with IM 
T3S components (Riordan and Schneewind, 2008) and co-purified 
with a complex containing the Yersinia ATPase YscN (Riordan et al., 
2008), it is possible that this interaction represents additional func-
tional roles for CdsO distinct from chaperone activity.
regulatIon of t3SS
regulatIon of gene expreSSIon
Chlamydial gene transcription is temporally regulated by incom-
pletely defined mechanisms and is generally classified as early-, 
mid-, and late-cycle. These times correspond roughly to key devel-
opmental events such as EB to RB conversion, active RB replication, 
and differentiation of RBs back to EBs, respectively (Abdelrahman 
and Belland, 2005). An apparent paradox in the early days of 
chlamydial T3S was the fact that de novo synthesis of apparatus 
components generally does not begin until mid-cycle. Moreover, 
genes encoding Scc2, CopB, and CopD are not transcribed until 
late-cycle (Fields and Hackstadt, 2006). Considerable work, includ-
ing identification of EB-localized T3S proteins (Vandahl et al., 2001; 
Fields et al., 2003) and secretion of T3S effectors such as TARP 
(Clifton et al., 2004) and CT694 (Hower et al., 2009) during inva-
sion, indicate that a T3SS is present and functional throughout 
chlamydial development. A reasonable model predicts that pre-
formed T3SSs in EBs mediate effector secretion during invasion and 
early development until replaced by de novo synthesized systems 
as RBs begin to divide.
Clues are beginning to emerge regarding how modulation of 
T3S gene expression is accomplished. RT-PCR transcriptional 
linkage  analysis  profiling  of  six  disseminated  T3SS-encoding 
loci revealed seven polycistronic operons preceded by predicted 
E. coli σ70-like promoter elements (Hefty and Stephens, 2007). 
Interestingly, quantitative gene expression provided evidence for 
three internal operons also possessing putative σ70-like promoters. 
These internal operons would result in expression of (i) cdsEF-
GHNOPQ, (ii) cdsJLRST, and (iii) cdsC independent from CT663-
cdsD, lpdA-lipA, and pkn5, respectively. It is currently unclear what 
would necessitate this separation. Transcriptional regulation of 
T3S genes in other organisms is primarily controlled by AraC-
like transcriptional activators which act in response to environ-
tus via a docking interaction with CdsQ (Spaeth et al., 2009). The 
Mcsc-effector-CdsQ interaction is not unique to Chlamydia since 
other CdsQ homologs have been shown to be capable of recogniz-
ing chaperone-effector complexes (Gonzalez-Pedrajo et al., 2006; 
Morita-Ishihara et al., 2006; Spaeth et al., 2009). What is unique 
is that Mcsc alone was able to bind to CdsQ, raising the interest-
ing possibility that Mcsc may be pre-docked at the T3S apparatus. 
Indeed, Mcsc partitioned within the EB IM in the absence of any 
effector cargo, and Cap1 and CT618 are synthesized at different time 
points post-invasion (Spaeth et al., 2009). Speath et al. speculate 
that either Mcsc dimers detach from CdsQ to stabilize newly synthe-
sized Cap1 and CT618, or more intriguingly, that the transcribing 
ribosome itself is recruited to the C-ring. If the latter proved to be 
the case it would be the first time that translational machinery has 
been shown to directly associate with the T3S apparatus.
Potential chlamydial Class II chaperones include CT274, Scc2, 
and Scc3 (Fields and Hackstadt, 2006). Despite conclusive sequence 
similarity with Yersinia SycD and the presence of TPR domains, 
in  silico  analyses  reveal  some  distinguishing  features  for  these 
proteins. It has previously been noted that T3SS chaperones are 
often small with an acidic pI (Feldman and Cornelis, 2003). Like 
homologs in other systems, CT274 is small (15.5 kDa) and has an 
acidic pI of 4.45, yet Scc2 and Scc3 do not fit either of these criteria 
at 26 and 23 kDa with pIs of 9.58 and 6.71, respectively. The larger 
mass corresponds to unique N-terminal regions of approximately 
60 residues that share little sequence similarity to each other or 
other chaperones. Despite these differences, in vitro studies demon-
strated that both Scc2 and Scc3 were capable of interacting with the 
Yersinia SycD substrate YopD, supportive of a conserved function. 
Work indicates an interaction of Scc2 with putative translocator 
proteins CopB (Fields et al., 2005; Spaeth et al., 2009) and CopD 
(Spaeth et al., 2009). Scc3 has been found to interact with CopB2 
(Fields et al., 2005) and with the C-terminal domain of CopN 
from C. trachomatis, C. pneumoniae and C. pscittaci, respectively 
(Slepenkin et al., 2005). Similar to Scc2 and Scc3, PSI-BLAST analy-
sis indicates a characteristic TPR domain within CT274. In contrast, 
specific homology with known T3SS chaperones is not apparent. 
Work by Spaeth et al. (2009) has identified an interaction of CT274 
with CT668 and CT161. CT161 represents a Chlamydia-specific 
hypothetical ORF, whereas the genomic positioning of CT688 
would suggest a role in the T3S apparatus, perhaps corresponding 
to Yersinia YscH/YopR (Blaylock et al., 2010). In support of this 
prediction and the need for a chaperone, the gene product cor-
responding to CT668 in C. pneumoniae is secreted (Subtil et al., 
2005; Muller et al., 2008).
Finally, chlamydial T3SS chaperones also include the recently 
identified Class III needle subunit co-chaperones CdsE and CdsG 
(Betts et al., 2008). CdsE and CdsG form a heteromeric complex 
(Betts et al., 2008; Spaeth et al., 2009) required for CdsF stabil-
ity. Secondary structure analysis of CdsE and CdsG demonstrated 
conserved features with other needle chaperones and gene order 
was conserved with Yersinia, Pseudomonas, and Bordetella (Betts 
et al., 2008). This is thus another example of chlamydial sequence 
divergence with functional and “genetic neighborhood” conserva-
tion (Betts et al., 2008; Lorenzini et al., 2010). This theme is further 
exemplified by the recently crystallized CT670, a Chlamydia-specific 
protein with no identifiable homologs outside of Chlamydia spp. www.frontiersin.org  October 2010  | Volume 1  | Article 114  |  9
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apparatus is   competent for secretion. The interaction of Scc3 with 
CopN noted above occurs through the domain having similarity 
to TyeA. Therefore, this could mediate CopN mobilization to the 
T3S apparatus or other, yet to be identified chaperones similar 
to SycN/YscB, could be involved. It is formally possible that the 
interaction of CopN with CdsN could also play a role (Stone et al., 
2008), but we favor an interpretation that this interaction merely 
reflects CdsN association with secretion substrates. Once CopN is 
secreted, it is unclear if substrate switching would then occur in 
Chlamydia spp. Although chlamydial genomes contain CdsU, it 
has not been determined whether this protein is cleaved similarly 
to Yersinia YscU to allow secretion of effector proteins (Riordan 
and Schneewind, 2008).
Secretion of mid- and late-cycle effectors (Valdivia, 2008; Betts 
et al., 2009) indicate secretion activity that is sustained presum-
ably until an RB dissociates from the inclusion membrane during 
differentiation to an EB. The environmental cues that result in this 
event remain undefined, but Wilson et al. (2009) have suggested 
that something as simple as space constraints within the inclusion 
dictate dissociation. Electron micrographs from multiple groups 
(Matsumoto, 1982a; Nichols et al., 1985) contain images of cylin-
drical surface projections emanating from RBs and forming direct 
connection with the inclusion membrane. Presuming that these 
structures correspond to CdsF-containing T3S filaments, enumera-
tion studies suggest that intra-inclusion space constraints result in 
fewer T3SSs making contact with a eukaryotic membrane (Wilson 
et al., 2006). This possibility raises a multitude of questions. For 
example, does CT671 correspond to a molecular ruler similar to 
Yersinia YscP (Journet et al., 2003; Riordan et al., 2008) and could it 
be involved in retracting CdsF-containing needles? Alternatively, is 
a more direct physical dissociation responsible for loss of contact? 
Since CT584 is a late-cycle gene product, does its de novo produc-
tion result in capping of needle filaments to cease secretion activ-
ity? Is secretion activity responding to dissociation or causing it? 
Are the uniquely late-cycle Scc2, CopB, and CopD involved in the 
process? Regardless of the precise mechanism, T3SS activity clearly 
corresponds to chlamydial development and represents an active 
area of current investigation.
addItIonal roleS In pathogeneSIS
As already noted, one way the T3S apparatus contributes directly 
to  chlamydial  pathogenesis  is  through  secretion  of  effector 
proteins affecting host cellular processes (Valdivia, 2008; Betts 
et al., 2009) and immunostimulatory capability (Prantner and 
Nagarajan, 2009). The secretion system may contribute indirectly 
to the host immune response, and therefore to immunopathol-
ogy, since injectisome components such as CopN elicit significant 
antibody responses during natural infection (Wang et al., 2010). 
It is additionally postulated, and highly likely, that the chlamydial 
T3SS is intimately involved in mediation of intracellular develop-
ment and absolutely essential to the developmental cycle; a concept 
that is in contrast to other T3SS containing organisms whereby 
the secretion system is essential for virulence but dispensable for 
survival (Wilson et al., 2006; Peters et al., 2007). We acknowl-
edge that separation of direct apparatus-mediated affects from 
developmental affects resulting from downstream responses to 
activities of secreted effectors will be complex. The impact(s) of 
mental cues encountered during infection; orthologs of which 
are conspicuously absent from the chlamydial genome (Darwin 
and Miller, 1999; Rakeman et al., 1999; Mavris et al., 2002; Akbar 
et al., 2003; Case et al., 2010). Recent data suggests that there are 
no explicit transcriptional activators of chlamydial T3S operons 
and that their temporal expression is under the control of general 
mechanisms. Specifically it was found that, as predicted by previ-
ous studies (Hefty and Stephens, 2007), promoters for all ten of 
the T3SS operons were transcribed in vitro by σ66, the major form 
of chlamydial RNA polymerase. Furthermore, these promoters 
were differentially sensitive to alterations in DNA supercoiling 
that corresponded to in vivo temporal expression patterns (Di 
Russo Case et al., 2010). Transcription of T3S mid-cycle promot-
ers was found to be activated in response to an increase in DNA 
supercoiling in a similar manner to other chlamydial mid-cycle 
promoters. Conversely, late cycle T3S promoters were insensitive 
to DNA supercoiling in accordance with several other supercoil-
ing-independent, σ66-regulated chlamydial late genes (Case et al., 
2010). This apparent lack of T3SS-specific transcriptional activa-
tors certainly makes intuitive sense for the coordination of T3SS 
expression with the overall Chlamydia   developmental cycle.
regulatIon of SecretIon actIvIty
The chlamydial T3SS is activated within minutes of contact with 
a eukaryotic cell (Clifton et al., 2004) and likely remains active so 
long as chlamydiae remain attached to the inclusion membrane 
(Fields  and  Hackstadt,  2006).  Similar  to  other  T3SSs  (Hueck, 
1998), the chlamydial system can therefore correctly be referred 
to as   contact-dependent. But what factors directly govern secretion 
activity? Several clues now exist, and initial attachment to the host 
plasma membrane likely represents the activation signal. In direct 
support of this notion, an in vitro release assay was adapted that was 
capable of stimulating release, albeit inefficiently, of invasion-re-
lated Tarp from cell-free EBs (Jamison and Hackstadt, 2008; Spaeth 
et al., 2009). Importantly, the stimuli, including the Ca2+ chelator 
EGTA, are also functional for other contact-activated T3SSs (Kim 
et al., 2005). It should be noted that activation of the chlamydial 
T3SS is likely more complicated given the metabolic inactivity and 
disulfide-bonded envelope of EBs. For example, we have empha-
sized that the presence of cysteine residues in CdsF is a feature 
unique to the chlamydial T3SS (Betts et al., 2008). Indeed, we find 
that EB, but not RB, CdsF cysteines are disulfide bonded (Betts-
Hampikian, unpublished). If these bonds interfere with secretion, 
reduction of EB-localized bonds would likely be required before 
full activity could be achieved.
Activation of secretion would also likely require concomitant 
secretion of CopN. Although secretion to the inclusion membrane 
is evident later in development (Fields and Hackstadt, 2000), com-
plications in immunolocalization sensitivity currently confound 
efforts  to  demonstrate  early  export.  CopN  contains  domains 
similar to Yersinia YopN and TyeA, two proteins involved in nega-
tive regulation of T3S. According to one plausible Yersinia model 
(Joseph and Plano, 2007), YopN is directed to the injectisome by 
the heterodimeric chaperone SycN/YscB but its secretion is pre-
vented by interaction with the apparatus through TyeA. Once 
the appropriate stimuli are detected by the needle/tip complex, 
the interaction with TyeA is dissolved, YopN is secreted, and the Frontiers in Microbiology  |  Cellular and Infection Microbiology    October 2010  | Volume 1  | Article 114  |  10
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are all   consistent with a predominant and direct role of T3S in 
developmental  progression.  Finally,  findings  that  the  putative 
Class I chaperone CT663 can exert a negative regulatory effect on 
σ66-dependent transcription (Rao et al., 2009) provide potential 
mechanisms by which secretion activity could feed-back to govern 
chlamydial gene expression on a global scale.
concludIng remarkS
One may reasonably question the logic and sanity of pursuing 
characterization of a complex secretion system in a genetically 
intractable organism. We have endeavored herein to provide an 
overview of current data describing the chlamydial T3SS and make 
forward-looking interpretations regarding unique biology. We cer-
tainly acknowledge that some of the discussed work represents 
preliminary characterization and the overall picture is far from 
complete. Indeed some studies, particularly those involving interac-
tion studies of ectopically expressed proteins, should be viewed with 
a level of caution. Given the unique physiology involved it is prob-
ably not possible to reconstitute the chlamydial T3SS in an amena-
ble host as was done for the Yersinia system (Bartra et al., 2006). As 
the field continues to mature however, the weight of accumulated 
evidence will doubtless validate findings that are physiologically 
relevant. Clearly, qualities regarding the chlamydial T3S appara-
tus remain to be elucidated. For example, several components of 
the basal apparatus are conspicuously absent from the chlamydial 
T3SS. A homolog of YscK and the inner rod protein YscI are not 
readily apparent. Whether these absences represent proteins that 
are present but remain to be discovered or are further examples of 
divergence of the chlamydial system remains to be seen. However, 
the most interesting studies will likely reveal how this intricate sys-
tem directly responds to and/or controls chlamydial development 
and therefore overall virulence.
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secretion and substrate activities are likely intimately entwined in 
the chlamydial system. Possibilities for direct roles of the apparatus 
do, however, exist. First, it is possible that the T3S apparatus con-
tributes to maintaining attachment of chlamydiae to eukaryotic 
membranes. We feel that it is unlikely that the T3SS is the sole 
mediator of initial attachment to plasma membranes. This concept 
is rare for T3SSs (Lara-Tejero and Galan, 2009) and evidence for 
a plethora of chlamydial attachment factors is abundant in the 
literature (Campbell and Kuo, 2006). Moreover, distinct varia-
tions exist among attachment requirements of different Chlamydia 
serovars and species (Dautry-Varsat et al., 2005) while surface-
exposed T3S components are highly conserved. However, it is 
much more likely that the T3S apparatus is directly involved in 
stable association with the inclusion membrane. Structures likely 
corresponding to T3S needles (Matsumoto, 1982a; Nichols et al., 
1985) conspicuously protrude through the inclusion membrane 
to potentially tether RBs. As noted above, these observations led to 
the hypothesis that T3S activity directly controls differentiation of 
RBs back into infectious EBs (Peters et al., 2007). In addition to the 
discussed mathematical models (Wilson et al., 2006), there is direct 
evidence to suggest that this may be the case. The recent discovery 
that certain acylated hydrazones of salicylaldehydes represent spe-
cific, small molecule inhibitors of T3SSs (Keyser et al., 2008) has 
provided a potentially valuable tool to investigate contributions 
of T3S to chlamydial development. We (Wolf et al., 2006) and 
others (Muschiol et al., 2006; Bailey et al., 2007; Slepenkin et al., 
2007) have shown that treatment of Chlamydia infected cultures 
with these inhibitors interferes with T3S and inhibits productive 
development of chlamydiae. It is not currently possible to rule 
out potential T3SS-independent effects on Chlamydia spp., and 
indirect effects such as chelation of iron likely contribute to the 
ability of inhibitors to interfere with chlamydial growth (Slepenkin 
et al. 2007). However, these studies are consistent in that drug 
treatment prevents conversion of RBs to EBs, reinforcing the pos-
sibility for a direct link between the T3SS and development. In 
addition, independent observations that (i) ectopic expression of 
the T3S effector IncA blocks development of C. caviae (Alzhanov 
et al., 2004), (ii) microinjection of neutralizing antibodies spe-
cific for the T3S effector CT229 arrest C. trachomatis development 
(Hackstadt et al., 1999; Rzomp et al., 2006), and (iii) inhibition of 
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